omniture
缔脉生物医药科技(上海)有限公司 DMED BIOPHARMACEUTICAL CO. LTD.

Latest News

dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing from New Investors

SHANGHAI and MORRISVILLE, N.C., July 7, 2021 /PRNewswire/ -- dMed-Clinipace, the global full-servic...

2021-07-07 20:00 2722

Recently Merged dMed and Clinipace Announce the Appointment of New Global COO

SHANGHAI and MORRISVILLE, N.C., May 21, 2021 /PRNewswire/ -- Following the recent merger announceme...

2021-05-21 20:00 4373

CROs dMed and Clinipace Merge to Accelerate Customer Success

SHANGHAI and MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ -- dMed Global, a full-service Clinical...

2021-04-28 20:00 2711

dMed Completed a US$100 Million Series C Financing

SHANGHAI, Dec. 17, 2020 /PRNewswire/ -- dMed, the clinical CRO with strong presence inChina and the...

2020-12-17 13:00 2432

dMed raises nearly US$50 million in Series B financing to strengthen and expand its clinical operations capability and global infrastructure

SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- dMed Biopharmaceutical Co., Ltd. recently announced complet...

2019-10-16 15:15 4515

Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies

SHANGHAI and NEW YORK, June 24, 2019 /PRNewswire/ -- Target Health Inc. and dMed Biopharmaceuticals...

2019-06-25 04:00 2106